Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data

[1]  C. You,et al.  Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients , 2018, Child's Nervous System.

[2]  A. King,et al.  Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database , 2017, Cancer.

[3]  Jie Ma,et al.  Atypical teratoid/rhabdoid tumours: clinicopathological characteristics, prognostic factors and outcomes of 22 children from 2010 to 2015 in China. , 2016, Pathology.

[4]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[5]  P. Julka,et al.  Intracranial atypical teratoid rhabdoid tumor: current management and a single institute experience of 15 patients from north India , 2015, Acta Neurochirurgica.

[6]  S. Khatua,et al.  Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. , 2014, International journal of radiation oncology, biology, physics.

[7]  Johan Lundgren,et al.  Long-term cognitive sequelae after pediatric brain tumor related to medical risk factors, age, and sex. , 2014, Pediatric neurology.

[8]  D. Brat,et al.  The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010. , 2014, Neuro-oncology.

[9]  O. Witt,et al.  High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB) , 2014, Bone Marrow Transplantation.

[10]  S. Bertolone,et al.  Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience , 2014, Pediatric blood & cancer.

[11]  I. Slavc,et al.  Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012 , 2013, Cancer medicine.

[12]  A. Trofimov,et al.  Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. , 2013, International journal of radiation oncology, biology, physics.

[13]  A. Gajjar,et al.  Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions , 2012, Front. Oncol..

[14]  K. Roberts,et al.  Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis , 2012, Cancer.

[15]  N. André,et al.  Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system , 2012, Cancer.

[16]  T. Merchant,et al.  Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. , 2012, International journal of radiation oncology, biology, physics.

[17]  J. Y. Lee,et al.  Atypical teratoid/rhabdoid tumors: the need for more active therapeutic measures in younger patients , 2012, Journal of Neuro-Oncology.

[18]  D. Johnston,et al.  Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. , 2012, European journal of cancer.

[19]  D. Lim,et al.  Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Young Children with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System , 2012, Journal of Korean medical science.

[20]  B. Hinkes,et al.  Frequency, Risk‐Factors and Survival of Children With Atypical Teratoid Rhabdoid Tumors (AT/RT) of the CNS Diagnosed between 1988 and 2004, and Registered to the German HIT Database , 2011, Pediatric blood & cancer.

[21]  H. Heinzl,et al.  Incidence of atypical teratoid/rhabdoid tumors in children , 2010, Cancer.

[22]  C. Hawkins,et al.  Atypical Teratoid or Rhabdoid Tumors: Improved Outcome With High-dose Chemotherapy , 2010, Journal of pediatric hematology/oncology.

[23]  C. Rodríguez-Galindo,et al.  Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors , 2010, Pediatric blood & cancer.

[24]  M. Prados,et al.  High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system , 2009, Journal of Neuro-Oncology.

[25]  R. Barr,et al.  Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System: A Meta-Analysis of Observational Studies , 2009, Journal of pediatric hematology/oncology.

[26]  R. Cozza,et al.  A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience , 2009, Journal of Neuro-Oncology.

[27]  J. Biegel,et al.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Finlay,et al.  Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors , 2008, Pediatric blood & cancer.

[29]  F. Rueda-Franco,et al.  Central nervous system atypical teratoid rhabdoid tumor: experience at the National Institute of Pediatrics, Mexico City , 2008, Child's Nervous System.

[30]  H. Budka,et al.  Immunohistochemical Analysis of INI1 Protein in Malignant Pediatric CNS Tumors: Lack of INI1 in Atypical Teratoid/Rhabdoid Tumors and in a Fraction of Primitive Neuroectodermal Tumors without Rhabdoid Phenotype , 2006, The American journal of surgical pathology.

[31]  Yi-Wei Chen,et al.  Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). , 2006, International journal of radiation oncology, biology, physics.

[32]  B. Scheithauer,et al.  Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  H Oka,et al.  Clinicopathological characteristics of atypical teratoid/rhabdoid tumor. , 1999, Neurologia medico-chirurgica.

[34]  J L Kepner,et al.  Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. , 1998, The American journal of surgical pathology.

[35]  F. Berthold,et al.  Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the german pilot trial HIT'88/'89. , 1998, Klinische Padiatrie.

[36]  J. Biegel,et al.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. , 1996, Journal of neurosurgery.

[37]  T. Olson,et al.  Successful Treatment of Disseminated Central Nervous System Malignant Rhabdoid Tumor , 1995, Journal of pediatric hematology/oncology.

[38]  T. Athanasiou,et al.  Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature , 2015, Journal of Neuro-Oncology.

[39]  T. Lomax,et al.  Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid Tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy , 2014, Journal of Neuro-Oncology.